1 Start 2 Complete

Please rate the following statements as they apply (agree, disagree, or N/A) *

	Strongly agree	Agree	Disagree	Strongly Disagree	N/A
The session content will be useful in my research career.	The session content will be useful in my research career. - Strongly agree	The session content will be useful in my research career. - Agree	The session content will be useful in my research career. - Disagree	The session content will be useful in my research career. - Strongly Disagree	The session content will be useful in my research career. - N/A
As a result of participating in this activity, I have improved my knowledge and competence in defining a clinical trial research question.	As a result of participating in this activity, I have improved my knowledge and competence in defining a clinical trial research question. - Strongly agree	As a result of participating in this activity, I have improved my knowledge and competence in defining a clinical trial research question. - Agree	As a result of participating in this activity, I have improved my knowledge and competence in defining a clinical trial research question. - Disagree	As a result of participating in this activity, I have improved my knowledge and competence in defining a clinical trial research question. - Strongly Disagree	As a result of participating in this activity, I have improved my knowledge and competence in defining a clinical trial research question. - N/A
The educational delivery method selected for the talks was effective.	The educational delivery method selected for the talks was effective. - Strongly agree	The educational delivery method selected for the talks was effective. - Agree	The educational delivery method selected for the talks was effective. - Disagree	The educational delivery method selected for the talks was effective. - Strongly Disagree	The educational delivery method selected for the talks was effective. - N/A
The suggested readings for each topic were helpful to my understanding of the session content.	The suggested readings for each topic were helpful to my understanding of the session content. - Strongly agree	The suggested readings for each topic were helpful to my understanding of the session content. - Agree	The suggested readings for each topic were helpful to my understanding of the session content. - Disagree	The suggested readings for each topic were helpful to my understanding of the session content. - Strongly Disagree	The suggested readings for each topic were helpful to my understanding of the session content. - N/A
The small group mentoring session was valuable in helping me develop my clinical trial concept.	The small group mentoring session was valuable in helping me develop my clinical trial concept. - Strongly agree	The small group mentoring session was valuable in helping me develop my clinical trial concept. - Agree	The small group mentoring session was valuable in helping me develop my clinical trial concept. - Disagree	The small group mentoring session was valuable in helping me develop my clinical trial concept. - Strongly Disagree	The small group mentoring session was valuable in helping me develop my clinical trial concept. - N/A
Learning about my peers’ concepts improved my understanding of clinical trials development.	Learning about my peers’ concepts improved my understanding of clinical trials development. - Strongly agree	Learning about my peers’ concepts improved my understanding of clinical trials development. - Agree	Learning about my peers’ concepts improved my understanding of clinical trials development. - Disagree	Learning about my peers’ concepts improved my understanding of clinical trials development. - Strongly Disagree	Learning about my peers’ concepts improved my understanding of clinical trials development. - N/A

Which session topic(s) was/were most impactful to you? (choose all that apply) *

Defining the Challenges in Conducting Modern-Day Trials

Adjuvant Treatment – Why are nearly all gynecologic cancers treated with carboplatin/paclitaxel and where do we go from here?

Role of surgery in the treatment of gynecologic malignancies

Adapting immune therapy for gynecologic cancers

Targeted therapies for gynecologic cancers

Was there a topic that you wish had been covered during this session? *

Which presenters(s) was/were most impactful to you? *

Amanda Fader

Sarah Adams

Robert Coleman

Anil Sood

Roisin O'Cearbhaill

Kunle Odunsi

Brad Monk

Katherine Fuh

Was there a small group mentor(s) that was/were particularly helpful with clinical trial concept development? *

Becca ArendKim LeslieBrad MonkShannon WestinMike BookmanRamez EksanderStephanie GaillardKunle OdunsiGloria HuangBrian SlomovitzDavid GershensonJoyce LiuFiona SimpkinsAnil SoodLisa BarroilhetRob ColemanKatherine FuhRoisin O'CearbhaillDanielle EnserroAustin MillerN/A

Do you have any feedback to improve the small group mentoring sessions? *

Please provide any additional feedback regarding the Jan 25, 2023 BRIDGES in-person session.

Leave this field blank